Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Equity Ratio (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Equity Ratio for 2 consecutive years, with 0.65 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 17.23% to 0.65 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.65, a 17.23% decrease, with the full-year FY2024 number at 0.77, changed N/A from a year prior.
  • Equity Ratio was 0.65 for Q3 2025 at Pyxis Oncology, down from 0.71 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.84 in Q1 2024 to a low of 0.65 in Q3 2025.